ManageSource Research, Inc. Initiates Research Coverage of Omni Medical Holdings, Inc. (OTC BB: ONMH)

ManageSource Research, Inc. announced today that it is initiating coverage of Omni Medical Holdings, Inc. (OTC BB: ONMH) with a Speculative Buy rating and an intrinsic value target of $0.70 - $1.10 based upon forward projected levels of growth through acquisition, organic development, and potential profitability. Ratio analysis has demonstrated that the Company has been improving in many categories, including internal liquidity and operating margins. The transaction recently announced by the Company should help to continue that trend and facilitate their growth strategy. Omni Medical Holdings, Inc. provides medical billing, collection and transcription services to medical practitioners across the United States through its wholly owned subsidiary, Omni Medical Services, Inc. Omni Medical is seeking out new acquisitions that are compatible with its desired intent to expand and become a national provider of medical billing and transcription services.

The complete report is available from http://www.managesource.com.

About ManageSource Research, Inc.

Founded in 1998, ManageSource is a California Registered Investment Advisor that provides custom independent equity research, forecasting, valuation analysis and research support services for hedge funds, institutional asset managers and corporations. For a complete list of ManageSource's current independent and enrolled research inventory and any associated disclosures, see: http://www.managesource.com/reports/msr_cvrg_discl.pdf.

Safe Harbor & Disclaimer:

ManageSource Research, Inc. reports are an information source only, not a solicitation in securities. Statements pertaining to a company's future value and growth potential are considered "forward-looking" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. ManageSource intends that such statements and all forward-looking statements be subject to the safe harbors created thereby. Actual results may differ significantly from those expressed or implied. Information has been carefully compiled from sources deemed to be reliable, but accuracy is not guaranteed. This report is not investment advice. Investing in securities is speculative and carries a high degree of risk. All information should be independently verified. Investors need to perform their own due diligence with any investment decision to fully understand all risks. Reports are prepared by ManageSource Research, Inc., a California registered investment advisor, CRD# 131888. Officers, directors, and employees of Managesource Research, Inc. do not currently hold an equity position in the above-mentioned securities, but may from time to time. The Company named herein is part of ManageSource's enrolled research program. ManageSource has received 54,000 restricted common shares as a research enrollment fee, either directly from the company herein described, or a related third party, for the preparation & distribution of this report. Further information: info@managesource.com.

Contact: ManageSource Research, Inc. 8251 Blackburn Avenue Los Angeles, CA 90048 (323) 712-3000 info@managesource.com Omni Medical Holdings, Inc. 1107 Mt. Rushmore Road, Suite 2 Rapid City, SD 57701 (605) 718-0380 ceo@omnimedical.com